hotspot -WSS

hotspot

author：leisure time 2025-09-28 23:05:41 - browse：993

LONDON — Seeking to build up its pharma business, the Japanese conglomerate Asahi Kasei is moving to buy Swedish biotech Calliditas Therapeutics in a nearly $1.1 billion cash deal, the companies said Tuesday.

The firm’s offer of $19.68 per share amounts to an 83% premium versus Calliditas’ closing price on a Swedish exchange Monday. The Calliditas board has unanimously recommended that shareholders accept the offer, the company said, adding that it “aims to realize the benefits of being part of a larger platform” by being acquired.

Calliditas has an approved drug on the U.S. market called Tarpeyo, which treats a kidney disease called IgA nephropathy. The condition has in recent years attracted interest from a number of pharma companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Biden launches a new push to limit health care costs

focus

knowledge

WSS

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

What to know about a major upcoming Wegovy heart health study

What to know about OceanGate, the company behind the missing Titanic submersible

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

House panel to mark up pandemic

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Wikipedia

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Virginia high school admissions case could be legal follow

North Korean leader's powerful sister says warplanes repelled US spy plane

Walensky prepares to leave CDC — and Congress — behind

What to know about a major upcoming Wegovy heart health study

Hepatitis C has a cure — but many Americans still lack access to it

FDA approves Leqembi, a milestone in Alzheimer’s treatment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

UPS workers' union leader explains what's at stake as strike edges closer

Heart attack and stroke risk calculators need revising

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

hotspot

Neutralizing antibodies against HIV shows promise in children

Beach reads and more: STAT's 2023 summer book list

New research casts further doubt on a common procedure used with IVF

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Lecanemab for Alzheimer's is coming. Is the health system ready?

focus

focus

knowledge

focus